Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.
about
The Role of ERK1/2 in the Development of Diabetic CardiomyopathyNew Treatment Strategies for Alcohol-Induced Heart DamagePiperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.Reappraisal of metallothionein: Clinical implications for patients with diabetes mellitus.Cardiac fibrosis: new insights into the pathogenesisPioglitazone Induces Cardiomyocyte Apoptosis and Inhibits Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway
P2860
Q28075539-AF424F51-86D9-41FF-89A2-5C8AE3655503Q28078093-62A57F42-4C3F-4650-8BBA-85BC2700DB50Q33603596-3ED4F1B9-61C4-4536-9DCE-F8F3915E5802Q33776469-26B0BC23-7B3E-49DE-97A9-FAEE84E429E6Q33790719-8C6FD3B5-C8ED-4EA4-808F-AC0762D7F6F9Q46274356-100215EC-9C29-4F5B-8E87-4332B55478C1Q58757982-3708370C-691F-4812-AF28-E5FD9821E74BQ58804870-2CD656AE-759B-4AED-8BA6-0EC33BEE95E7
P2860
Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pioglitazone Protected against ...... β and MAPK Signaling Pathways.
@en
type
label
Pioglitazone Protected against ...... β and MAPK Signaling Pathways.
@en
prefLabel
Pioglitazone Protected against ...... β and MAPK Signaling Pathways.
@en
P2093
P2860
P356
P1433
P1476
Pioglitazone Protected against ...... β and MAPK Signaling Pathways.
@en
P2093
Ning Zhang
Qi-Zhu Tang
Wen-Ying Wei
Zhen-Guo Ma
P2860
P304
P356
10.1155/2016/9174190
P577
2016-03-27T00:00:00Z